35-Year-Old Male with Androgenetic Alopecia Treated with PRP, Oral Minoxidil, and Finasteride
Introduction
Androgenetic alopecia (male pattern hair loss) is the most common form of hair loss in men, caused by a combination of genetics, hormonal influence, and age-related factors. At our dermatology clinics in Houston and Katy, Texas, we provide comprehensive hair restoration treatment plans that combine medical therapy and advanced in-office procedures like platelet-rich plasma (PRP) and Alma TED.
This case highlights a 35-year-old male presenting with progressive hair thinning who initiated a personalized, multi-modal treatment regimen.
Patient Case
A 35-year-old man presented for evaluation of generalized scalp hair thinning that had been gradually progressing over the past year. The hair loss was moderate in severity, without a strong family history. The patient noted that he had been on testosterone therapy, which may have contributed to his recent hair shedding.
He previously tried stem cell treatments and had been using a compounded topical formula containing minoxidil, finasteride, dutasteride, retinoic acid (RA), triamcinolone (TAC), and copper peptides for about one year, with mild improvement. He expressed interest in further treatments such as PRP, Alma TED, and intradermal dutasteride injections.
Examination
A thorough scalp examination revealed diffuse thinning across the vertex and frontotemporal areas consistent with androgenetic alopecia (AGA). No signs of scarring or inflammation were present. The patient was alert, well-developed, and in no acute distress.
Diagnosis
Androgenetic Alopecia (L64.8)
Treatment Plan
After reviewing the patient’s history and treatment goals, we discussed all evidence-based options for hair restoration:
Oral finasteride or dutasteride
Platelet-rich plasma (PRP)
Future consideration of hair transplant
Following extensive counseling about benefits, expectations, and side effects, the patient elected to start the following combination regimen:
1. Oral Minoxidil – Start with 1.25 mg daily for one month; increase to 2.5 mg daily if well-tolerated.
2. Oral Finasteride (1 mg daily) – To block DHT and slow progression of androgenetic hair loss.
3. Platelet-Rich Plasma (PRP) Injections – First session performed today; plan to alternate PRP and Alma TED sessions every two weeks.
Counseling and Risks
Finasteride: Discussed potential side effects including decreased libido, gynecomastia, and mood changes.
Oral Minoxidil: Reviewed risks of dizziness, ankle swelling, rapid heartbeat, and unwanted hair growth.
PRP Procedure: Discussed possible pain, infection, bruising, or incomplete improvement.
Baseline photos were taken for progress tracking.
Procedure Summary: PRP Treatment #1
A total of 7 cc of PRP was prepared from the patient’s own blood and injected into the scalp under sterile conditions. The procedure was well-tolerated without complications.
Aftercare:
Wash hair with a gentle, sulfate-free shampoo after 24 hours.
Continue existing topical or oral hair loss therapies.
Avoid hair coloring for 2–3 days.
Follow-Up
The patient will return in 2 weeks for his first Alma TED treatment, with a plan to alternate PRP and TED sessions for optimal hair density improvement.
Discussion
This case highlights the growing trend of combination therapy for hair restoration—merging medical and procedural approaches. In men undergoing testosterone therapy, the hormonal influence of DHT can accelerate hair loss. By pairing finasteride and oral minoxidil with regenerative options like PRP and Alma TED, we aim to enhance both follicular growth and scalp health.
At Reena Jogi MD Dermatology in Houston and Katy, Texas, we tailor every hair loss plan to the patient’s needs, ensuring safe and effective results through medical science and aesthetic innovation. Call the office at 7134874061 to book your consultation now!
